A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder

@article{Rickels2004ADP,
  title={A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder},
  author={K. Rickels and R. Mangano and A. Khan},
  journal={Journal of Clinical Psychopharmacology},
  year={2004},
  volume={24},
  pages={488-496}
}
Abstract: Venlafaxine extended release (ER) is a dual serotonin-norepinephrine reuptake inhibitor previously shown to be effective in the treatment of major depressive disorder and generalized anxiety disorder. This placebo-controlled, multicenter, randomized, double-blind trial examined the efficacy and safety of venlafaxine ER in outpatients with generalized social anxiety disorder. Two hundred seventy-two outpatients were randomly assigned to receive either a flexible dose of venlafaxine ER… Expand
87 Citations

Paper Mentions

Interventional Clinical Trial
Previous studies have demonstrated that venlafaxine significantly improves the language function of healthy subjects and increase of fMRI activation in cortical language area. This… Expand
ConditionsIschemic Stroke, Subcortical Aphasia
InterventionDrug
Long-term efficacy of pregabalin in generalized anxiety disorder
  • 108
Mirtazapine Treatment of Social Phobia in Women: A Randomized, Double-Blind, Placebo-Controlled Study
  • 60
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
  • 200
...
1
2
3
4
5
...